How does middle east respiratory syndrome spread?(Mar 2024)

 

How does middle east respiratory Syndrome(Virus) spread?(Mar 2024)

Middle East respiratory syndrome coronavirus (MERS-CoV) is a viral respiratory disease caused by a novel coronavirus that was first identified in 2012. It is a zoonotic virus, meaning it is transmitted between animals and people, with dromedary camels identified as a source of infection. The symptoms of MERS-CoV infection range from no symptoms or mild respiratory symptoms to severe illness, including fever, cough, shortness of breath, and pneumonia. Severe cases can lead to respiratory failure requiring intensive care. 

Human-to-human transmission is possible, mainly among close contacts and in healthcare settings. Prevention involves avoiding contact with camels, consuming properly cooked camel products, and practicing good hygiene. There is no specific treatment or vaccine for MERS-CoV, but research is ongoing to develop them.

Middle east respiratory syndrome

Middle East respiratory syndrome (MERS) is a viral respiratory illness caused by the Middle East respiratory syndrome-related coronavirus (MERS-CoV). It was first reported in Saudi Arabia in 2012 and has since spread to several other countries, including the United States. MERS-CoV infections range from no symptoms or mild respiratory symptoms to severe illness, including fever, cough, and shortness of breath. Pneumonia is a common finding, but not always present. 

Gastrointestinal symptoms, including diarrhoea, have also been reported. Severe illness can cause respiratory failure that requires mechanical ventilation and support in an intensive care unit. The virus is zoonotic, meaning it is transmitted between animals and people, with dromedary camels identified as a source of infection. Human-to-human transmission is possible, but it is not very contagious between people unless they are in close contact. As of 2021, there is no specific treatment or vaccine for MERS-CoV, but research is ongoing to develop them.

How can mers-cov be prevented

To prevent MERS-CoV infection, the following measures can be taken:

1. Hand hygiene: Wash hands frequently with soap and water for at least 20 seconds, or use an alcohol-based hand sanitizer.
2. Respiratory hygiene: Cover the mouth and nose with a tissue when coughing or sneezing, then throw the tissue in the trash.
3. Avoid personal contact: Avoid kissing, sharing cups or eating utensils, and touching the eyes, nose, and mouth with unwashed hands.
4. Clean and disinfect surfaces: Clean and disinfect frequently touched surfaces and objects, such as doorknobs.
5. Personal protective equipment (PPE): Healthcare workers should use appropriate PPE, including eye protection, masks, and gloves, when caring for patients with MERS-CoV.
6. Avoid contact with camels: People with diabetes, renal failure, chronic lung disease, and immunocompromised individuals should avoid contact with camels, drinking raw camel milk or camel urine, or eating meat that has not been properly cooked.
   
   
7. Avoid travel to affected areas: Travelers with chronic conditions should take extra precautions when visiting farms or markets where camels are present.
8. Report suspected cases: Report any suspected cases to local health authorities.
9. Minimize close contact: Minimize close contact with anyone who develops an acute respiratory illness with fever.
10. Seek medical attention: Seek immediate medical attention if an acute respiratory illness with a fever develops within 14 days of returning from an area where MERS-CoV is known to be circulating.

There is currently no specific antiviral treatment recommended for MERS-CoV infection, and treatment is supportive and based on the patient's clinical condition.

Treatment

The treatment for Middle East respiratory syndrome (MERS) involves supportive care to relieve symptoms, as there is no specific antiviral treatment recommended for MERS-CoV infection. Individuals with MERS often receive medical care to help alleviate symptoms. For severe cases, current treatment includes care to support vital organ functions. Some pharmacologic treatments have been explored, including antiviral drugs like lopinavir/ritonavir, oseltamivir, ribavirin, and interferons. 

Additionally, supportive care measures such as extracorporeal membrane oxygenation (ECMO) have been used for severe cases of MERS. Most patients with severe MERS are cared for in an intensive care unit (ICU). It is important to note that no vaccination against MERS-CoV infection currently exists, and the World Health Organization (WHO) and the US Centers for Disease Control and Prevention (CDC) recommend general infection prevention measures.

Coronavirus mers cov

Middle East respiratory syndrome coronavirus (MERS-CoV) is a zoonotic virus that can be transmitted between animals and humans, with dromedary camels identified as a source of infection. The virus causes a range of symptoms from no symptoms or mild respiratory issues to severe acute respiratory disease and death. Common symptoms include fever, cough, shortness of breath, and pneumonia. Severe cases may lead to respiratory failure requiring mechanical ventilation and intensive care support. MERS-CoV has been identified in dromedaries in various countries in the Middle East, Africa, and South Asia, with human-to-human transmission possible but mainly occurring among close contacts and in healthcare settings. 

Currently, there is no specific treatment or vaccine available for MERS-CoV, but several vaccines and treatments are in development. Prevention measures include practicing good hygiene, avoiding contact with camels or their products, and following infection prevention and control measures in healthcare facilities to minimize the spread of the virus.

Mers test

Laboratory testing for Middle East respiratory syndrome coronavirus (MERS-CoV) involves different methods to detect the virus and assess infection status. Here are some key points from the search results:

1. Molecular Tests: These tests are used to diagnose active MERS-CoV infection by detecting the presence of the virus. Real-time reverse-transcription polymerase chain reaction (rRT-PCR) assays are commonly used for this purpose. The success of these tests depends on various factors, including the type and condition of specimens being tested. Multiple specimens, including respiratory samples like sputum and nasopharyngeal swabs, serum, and stool specimens, may be collected for testing.
2. Serology Tests: Serology testing is used to detect previous MERS-CoV infection by identifying antibodies to the virus. These tests are not typically used for diagnostic purposes but rather for surveillance or investigational purposes. Serology tests can help determine if a person has been previously infected with MERS-CoV by detecting specific antibodies produced by the immune system in response to the virus.
3. Testing Process: When a possible MERS case is suspected, samples should be obtained and sent to a MERS testing laboratory within 12 hours of suspicion. The recommended minimum diagnostic sample set includes an upper respiratory tract sample (such as a combined nose and throat viral swab) and a lower respiratory tract sample (e.g., sputum or endotracheal tube aspirate). Samples should be handled at Containment Level 3 in sample handling laboratories.
4. Reporting and Notification: The initial MERS testing result should be reported within 24 hours of sample receipt in the testing laboratory. Clinicians must notify local health protection teams about possible cases during both regular hours and out-of-hours, following specific notification procedures.

Summary 

Laboratory testing for MERS-CoV involves molecular tests like rRT-PCR assays to detect active infection and serology tests to identify previous exposure through antibody detection. Timely sample collection, appropriate handling, and notification procedures are crucial aspects of the testing process.